Hypoxanthine as a measurement of hypoxia.
The hypoxanthine concentration in plasma was found to be a sensitive parameter of hypoxia of the fetus and the newborn infant. The plasma level of hypoxanthine in the umbilical cord in 29 newborn infants with normal delivery varied between 0 and 11.0 mumol/liter with a mean of 5.8 mumol/liter, SD 3.0 mumol/liter. Compared with this reference group the hypoxanthine concentration in plasma of the umbilical cord in 10 newborn infants with clinical signs of intrauterine hypoxia during labor was found to be significantly higher, with a range of 11.0-61.5 mumol/liter, with a mean of 25.0 mumol/liter, SD 18.0 mumol/liter. The plasma level of hypoxanthine in two premature babies developing an idiopathic respiratory distress syndrome was monitored. The metabolite was found to be considerably increased, in one of them more than 24 hr after a period of hypoxia necessitating artificial ventilation. The hypoxanthine level in plasma of umbilical arterial blood was followed about 2 hr postpartum in three newborn infants with clinical signs of intrauterine hypoxia. The decrease of the plasma concentration of the metabolite seemed to be with a constant velocity, as it was about 10 mumol/liter/hr in these cases. A new method was used for the determination of hypoxanthine in plasma, based on the principle that PO2 decreased when hypoxanthine is oxidized to uric acid.
D001034:Apgar Score; D005333:Fetus; D006801:Humans; D007042:Hypoxanthines / Q000097:blood*; D000860:Hypoxia / Q000097:blood / Q000175:diagnosis*; D007231:Infant, Newborn; D007288:Inosine / Q000097:blood; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis; D014527:Uric Acid / Q000096:biosynthesis
D007042:Hypoxanthines; D014527:Uric Acid; D007288:Inosine